Mineral metabolism in dimethylnitrosamine-induced hepatic fibrosis

Clinical Biochemistry

Volumn 39, Issue 10, 2006, Pages 984-991

  George, Joseph ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Ascites; Dimethylnitrosamine; Essential elements; Hepatic fibrosis; Liver cirrhosis; Mineral metabolism; Minerals; N nitrosodimethylamine

Indexed keywords

ALBUMIN; CALCIUM; DIMETHYLNITROSAMINE; MAGNESIUM; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; ATOMIC ABSORPTION SPECTROMETRY; BODY WEIGHT; CONTROLLED STUDY; LIVER; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER INJURY; MALE; MINERAL METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM;

ANIMALS; ASCITES; BODY WEIGHT; CALCIUM; DIMETHYLNITROSAMINE; LIVER; LIVER CIRRHOSIS; MAGNESIUM; MALE; MINERALS; ORGAN SIZE; POTASSIUM; RATS; RATS, WISTAR;

EID: 33748973233     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.07.002     Document Type: Article

References (47)

1. McDowell L.E. Minerals in animal and human nutrition. 2nd ed. (2003), Elsevier Science, Amsterdam 1-630
2. Rosner M.H., Gupta R., Ellison D., and Okusa M.D. Management of cirrhotic ascites: physiological basis of diuretic action. Eur. J. Intern. Med. 17 (2006) 8-19
3. Sandhu B.S., and Sanyal A.J. Management of ascites in cirrhosis. Clin. Liver Dis. 9 (2005) 715-732
4. Arroyo V., Badalamenti S., and Gines P. Pathogenesis of ascites in cirrhosis. Minerva Med. 78 (1987) 645-650
5. Castello L., Pirisi M., Sainaghi P.P., and Bartoli E. Hyponatremia in liver cirrhosis: pathophysiological principles of management. Dig. Liver Dis. 37 (2005) 73-81
6. Castello L., Pirisi M., Sainaghi P.P., and Bartoli E. Quantitative treatment of the hyponatremia of cirrhosis. Dig. Liver Dis. 37 (2005) 176-180
7. Borroni G., Maggi A., Sangiovanni A., Cazzaniga M., and Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig. Liver Dis. 32 (2000) 605-610
8. Weiner I.D., and Wingo C.S. Hypokalemia-Consequences, causes, and correction. J. Am. Soc. Nephrol. 8 (1997) 1179-1188
9. Castro A., Ros J., Jimenez W., et al. Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. J. Hepatol. 21 (1994) 521-526
10. George J., Tsutsumi M., and Takase S. Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats. Int. J. Biochem. Cell Biol. 36 (2004) 307-319
11. George J., and Chandrakasan G. Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int. J. Biochem. Cell Biol. 28 (1996) 353-361
12. George J., and Chandrakasan G. Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin. Biochem. 33 (2000) 563-570
13. Jenkins S.A., Grandison A., Baxter J.N., Day D.W., Taylor I., and Shields R. A dimethylnitrosamine induced model of cirrhosis and portal hypertension in the rat. J. Hepatol. 1 (1985) 489-499
14. George J., Rao K.R., Stern R., and Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 156 (2001) 129-138
15. Woessner Jr. J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93 (1961) 440-447
16. George J., and Chandrakasan G. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim. Biophys. Acta 1292 (1996) 215-222
17. Sunderman F.W., and Carroll J.E. Measurements of serum calcium and magnesium by atomic absorption spectrometry. Am. J. Clin. Pathol. 43 (1965) 302-310
18. George J., and Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin. Chim. Acta 348 (2004) 189-197
19. George J., and Chandrakasan G. Lactate dehydrogenase isoenzymes in dimethylnitrosamine induced hepatic fibrosis in rats. J. Clin. Biochem. Nutr. 22 (1997) 51-62
20. George J. Ascorbic acid concentrations in dimethylnitrosamine-induced hepatic fibrosis in rats. Clin. Chim. Acta 335 (2003) 39-47
21. Papadakis M.A., and Arieff A.I. Hyponatremia and hypernatremia in liver disease. In: Epstein M. (Ed). The kidney in liver disease. 3rd ed. (1988), Williams and Wilkins, Baltimore 73-88
22. Sullivan J.F., Blotcky A.J., Jetton M.M., Hahn H.KJ., and Burch R.E. Serum levels of selenium, calcium, copper, magnesium, manganese and zinc in various human diseases. J. Nutr. 109 (1979) 1432-1437
23. Rodriguez-Perez F., Isales C.M., and Groszmann R.J. Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis. Gastroenterology 105 (1993) 863-867
24. Morgan M.Y. Alcohol and nutrition. Br. Med. Bull. 38 (1982) 21-30
25. Nakano A., Kanda T., and Abe H. Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis. J. Gastroenterol. Hepatol. 11 (1996) 1143-1154
26. Masuda S., Okano T., Osawa K., Shinjo M., Suematsu T., and Kobayashi T. Concentrations of vitamin D binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J. Nutr. Sci. Vitaminol. 35 (1989) 225-234
27. Bengoa J.M., Sitrin M.D., Meredith S., et al. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology 4 (1984) 261-265
28. Evans C.H., and Drouven B.J. The promotion of collagen polymerization by lanthanide and calcium ions. Biochem. J. 213 (1983) 751-758
29. Reuben P.M., Brogley M.A., Sun Y., and Cheung H.S. Molecular mechanism of the induction of metalloproteinases-1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha. J. Biol. Chem. 277 (2002) 15190-15198
30. Reuben P.M., Wenger L., Cruz M., and Cheung H.S. Induction of matrix metalloproteinase-8 in human fibroblasts by basic calcium phosphate and calcium pyrophosphate dihydrate crystals: effect of phosphocitrate. Connect. Tissue Res. 42 (2001) 1-12
31. McCarthy G.M., Westfall P.R., Masuda I., Christopherson P.A., Cheung H.S., and Mitchell P.G. Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes. Ann. Rheum. Dis. 60 (2001) 399-406
32. Oide H., and Thurman R.G. Hepatic Ito cells contain calcium channels: increases with transforming growth factor-beta 1. Hepatology 20 (1994) 1009-1014
33. Tam M., Gomez S., Gonzalez-Gross M., and Marcos A. Possible roles of magnesium on the immune system. Eur. J. Clin. Nutr. 57 (2003) 1193-1197
34. Suzuki K., Oyama R., Hayashi E., and Arakawa Y. Liver diseases and essential trace elements. Nippon Rinsho 54 (1996) 85-92
35. Rocchi E., Borella P., Borghi A., et al. Zinc and magnesium in liver cirrhosis. Eur. J. Clin. Invest. 24 (1994) 149-155
36. Dashti H., Jeppsson B., Abdulla M., Srinivas U., Hagerstrand I., and Bengmark S. Changes in the plasma levels of copper, zinc, calcium, magnesium and selenium in thioacetamide induced liver cirrhosis. Acta Pharm. Toxicol. Copenhagen 59 Suppl 7 (1986) 219-222
37. Cohen L. Magnesium and liver cirrhosis. Met. Ions Biol. Syst. 26 (1990) 271-284
38. Pitts T.O., and Van-Thiel D.H. Disorders of the serum electrolytes, acid-base balance, and renal function in alcoholism. Recent Dev. Alcohol. 4 (1986) 311-339
39. Perez G.O., and Oster J.R. Altered potassium metabolism in liver disease. In: Epstein M. (Ed). The kidney in liver disease. 2nd ed. (1983), Elsevier Science Publishers 183-202
40. Podolsky S., Zimmerman H.J., Burrows B.A., Cardarelli J.A., and Pattavina C.G. Potassium depletion in hepatic cirrhosis. Reversible cause of impaired growth hormone and insulin response to stimulation. N. Engl. J. Med. 288 (1973) 644-648
41. Thier S.O. Potassium physiology. Am. J. Med. 80 (1986) 3-7
42. Vitale G.C., Neill G.D., Fenwick M.K., Stewart W.W., and Cuschieri A. Body composition in the cirrhotic patient with ascites: assessment of total exchangeable sodium and potassium with simultaneous serum electrolyte determination. Am. Surg. 51 (1985) 675-681
43. Bernardi M., Trevisani F., Fornale L., et al. Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining. J. Hepatol. 21 (1994) 1116-1122
44. Wong F., and Blendis L. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor. Semin. Liver Dis. 14 (1994) 59-70
45. Wu C.C., Yeung L.K., Tsai W.S., et al. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin. Nephrol. 65 (2006) 28-33
46. Koller H., and Rosenkranz A. Hyponatremia to be an excellent predictor of outcome in patients with advanced cirrhosis. Liver Transpl. 11 (2005) 336-343
47. Rocco V.K., and Ware A.J. Cirrhotic ascites. Pathophysiology, diagnosis, and management. Ann. Intern. Med. 105 (1986) 573-585